New 2-Piperazinylbenzimidazole Derivatives as 5-HT3Antagonists. Synthesis and Pharmacological Evaluation
- 1 February 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (4) , 586-593
- https://doi.org/10.1021/jm960442e
Abstract
A series of 2-piperazinylbenzimidazole derivatives were prepared and evaluated as 5-HT3 receptor antagonists. Their 5-HT3 receptor affinities were evaluated by radioligand binding assays, and their abilities to inhibit the 5-HT-induced Bezold−Jarisch reflex in anesthetized rats were determined. Compound 7e (lerisetron, pKi = 9.2) exhibited higher affinity for the 5-HT3 receptor than did tropisetron and granisetron, while compound 7q (pKi = 7.5) had very low affinity for this receptor, showing that substitution on the N1 atom of the benzimidazole ring is essential for affinity and activity. The effect of substitution on the aromatic ring of benzimidazole by several substituents in different positions is also discussed. A strong correlation between the 5-HT3 antagonistic activity of the studied compounds and the position of substitution on the aromatic ring was established. Thus, while the 4-methoxy derivative 7m showed weak affinity for the 5-HT3 receptor (pKi = 6.7), the 7-methoxy derivative 7n exhibited the highest affinity (pKi = 9.4). Compounds 7e and 7n are now under further investigation as drugs for the treatment of nausea and emesis evoked by cancer chemotherapy and radiation.Keywords
This publication has 25 references indexed in Scilit:
- ErratumTrends in Pharmacological Sciences, 1993
- Clinical evaluation of 5-HT3 receptor antagonists as anti-emeticsTrends in Pharmacological Sciences, 1991
- 5-HT3 Receptor AntagonistsDrugs, 1991
- 5‐HT3 receptorsMedicinal Research Reviews, 1990
- Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several speciesEuropean Journal of Pharmacology, 1989
- Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron)European Journal of Pharmacology, 1989
- 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterizationTrends in Neurosciences, 1988
- Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptorsBritish Journal of Pharmacology, 1988
- FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESISThe Lancet, 1987
- SERUM VASOCONSTRICTOR (SEROTONIN)Journal of Biological Chemistry, 1948